• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

MAUDE Adverse Event Report: ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 

ABBOTT DIAGNOSTICS SCARBOROUGH, INC. BINAXNOW COVID-19 AG SELF TEST 2CT; CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM. Back to Search Results
Catalog Number 195-160
Device Problems No Apparent Adverse Event (3189); Non Reproducible Results (4029)
Patient Problem No Clinical Signs, Symptoms or Conditions (4582)
Event Date 01/01/2024
Event Type  malfunction  
Manufacturer Narrative
Date of event provided in section b3 is an approximation, was not provided by consumer.The intake information required to enable further investigation, such as the kit¿s lot number, was not provided and an investigation was not able to be performed.Notwithstanding, a review of complaints¿ trend reveals that all lots within expiry dating are performing according to the statements made in the package insert.In conclusion, abbott diagnostics scarborough was unable to determine the exact root cause of the reported issues as no information was provided for investigation.
 
Event Description
The consumer reported conflicting results with the binaxnow covid-19 antigen self-test performed on an unknown date.Per the consumer, the first test taken generated a positive result and the second test conducted and generated negative result.Confirmation testing was not performed.No additional patient information, including treatment and outcome, was provided.
 
Event Description
The consumer reported a positive result with the pcr at urgent care on (b)(6) 2023 and prescribed paxlovid as a result.The consumer proceeded with 2 binaxnow covid-19 antigen self-test performed on (b)(6) 2023 both generated positive results.Additionally, the consumer performed a third binaxnow covid-19 antigen self-test on (b)(6) 2024 and generated a negative result.No additional patient information, including treatment and outcome, was provided.
 
Manufacturer Narrative
Updated b5: customer provided additional information on 15apr2024 indicated that they performed one (1) pcr test and three (3) binaxnow tests.Abbott medical affair was consulted regarding the updated information, which provided that given the information that the patient tested negative after 3 days on paxlovid treatment, the negative results on (b)(6) 2024 is most likely truly reflecting the disease recovery progress rather than a false negative.  date of event provided in section b3 is an approximation, was not provided by consumer.The intake information required to enable further investigation, such as the kit¿s lot number, was not provided and an investigation was not able to be performed.Notwithstanding, a review of complaints¿ trend reveals that all lots within expiry dating are performing according to the statements made in the package insert.In conclusion, abbott diagnostics scarborough was unable to determine the exact root cause of the reported issues as no information was provided for investigation.
 
Search Alerts/Recalls

  New Search  |  Submit an Adverse Event Report

Brand Name
BINAXNOW COVID-19 AG SELF TEST 2CT
Type of Device
CORONAVIRUS ANTIGEN DETECTION TEST SYSTEM.
Manufacturer (Section D)
ABBOTT DIAGNOSTICS SCARBOROUGH, INC.
10 southgate road
scarborough ME 04074
Manufacturer Contact
rachel blackwell
10 southgate road
scarborough, ME 04074
6613888803
MDR Report Key18998962
MDR Text Key338885345
Report Number1221359-2024-00304
Device Sequence Number1
Product Code QKP
Combination Product (y/n)N
Reporter Country CodeUS
PMA/PMN Number
EUA210264
Number of Events Reported1
Summary Report (Y/N)N
Report Source Manufacturer
Source Type Consumer
Reporter Occupation Non-Healthcare Professional
Type of Report Initial,Followup
Report Date 04/24/2024
1 Device was Involved in the Event
1 Patient was Involved in the Event
Date FDA Received03/28/2024
Is this an Adverse Event Report? No
Is this a Product Problem Report? Yes
Device Operator Lay User/Patient
Device Catalogue Number195-160
Was Device Available for Evaluation? No
Date Manufacturer Received04/15/2024
Was Device Evaluated by Manufacturer? No
Is the Device Single Use? Yes
Is This a Reprocessed and Reused Single-Use Device? No
Type of Device Usage Initial
Patient Sequence Number1
-
-